HSBC investors are backing CEO George Elhedery's decision to shut parts of its investment bank in the Americas and Europe, aligning with the bank's strategic focus on Asia. Four shareholders, including two of HSBC's top 20 investors, expressed support for axing mergers and equity capital markets teams, citing stronger opportunities in Asian markets.
Once spanning over 100 countries, HSBC has spent the last decade streamlining operations. With U.S. tariffs posing risks to trade finance providers like HSBC, Elhedery faces pressure to reallocate capital to resilient Asian economies. Alex Potter of HSBC shareholder abrdn highlighted global geopolitical challenges and the limited success of foreign banks in U.S. equity investment banking.
Elhedery is expected to detail further cost-saving measures during HSBC's full-year results announcement on February 21. Media reports estimate savings between £1.2 billion and £3 billion through management cuts and further unit reductions. HSBC shares have risen 11.5% year-to-date after a 20% gain in 2024.
Sajeer Ahmed of Aegon Asset Management praised HSBC's meticulous business analysis aimed at achieving a 16% return on tangible equity (ROTE). HSBC's 19.3% ROTE in the first nine months of 2024 contrasts with its lower price-to-book ratio of 1.04 compared to Morgan Stanley's 2.16.
The restructuring aims to boost profitability and close valuation gaps with U.S. banks. HSBC's forecasted 2024 profit stands at $31.6 billion, following a 78% surge in 2023. However, internal concerns about job cuts and morale persist, particularly as Trump's deregulatory policies are expected to drive double-digit growth in investment banking. Despite challenges, HSBC's focus on Asian capital markets remains a key growth strategy.


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



